Shots:

• The company has submitted the chemistry, manufacturing and controls (CMC) data module, completing the final data packages required for the EUA application of NVX-CoV2373 with Matrix-M adjuvant
• Novavax is all set to file an application with the US FDA in 30 days, seeking EUA for its vaccine, as per the FDA guidance for all EUA applications for vaccines
• The company plans to later supplement the submission, with data from additional manufacturing sites across its global supply chain

Ref: Novavax | Image: Medpage Today